About Baxil Pharma Private Limited
Data last updated:
Baxil Pharma Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 December 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2005PTC144166. Its GSTIN is 05AACCB8894L1Z4 (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹1 Cr. It was formerly known as Baviera Pharmaceuticals Private Limited. It is led by directors including Anil Singh and Asha Singh.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Village Chilla Saronda Bangar In The Abadi Of Block – B New Ashok Nagar, Illaqa Shahdara, Delhi, India – 110096.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.62 Cr, a decline of 47% compared to the previous year. For the same year it recorded a net profit of ₹3.69 Lakh (net margin 1%) and EBITDA of ₹27.37 Lakh (EBITDA margin 7.6%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years and 1% over five years.
The company has about 17 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Baxil Pharma. As per MCA filings, the company has open charges of ₹90 Lakh and satisfied charges of ₹4.5 Cr on record. Court records list 23 cases involving the company, including 23 filed against it; 5 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website baxilpharma.com.
Company details
Contact details
Baxil Pharma Private Limited's registered office is in Delhi, Delhi. Its website is baxilpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressVillage Chilla Saronda Bangar In The Abadi Of Block – B New Ashok Nagar, Illaqa Shahdara, Delhi, India – 110096
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Baxil Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Baxil Pharma operates one associated brand: BAXIL PHARMA. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulation manufacturing and quality assurance in India. | baxilpharma.com |
Business activity
The main business activity of Baxil Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Baxil Pharma Private Limited, buy the company report.
Financials of Baxil Pharma Private Limited
FY 2025 filings availableBaxil Pharma Private Limited reported revenue of ₹3.62 Cr (down 47% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 47% fall in the latest year. EBITDA fell 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹27.37 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.69 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.6% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Baxil Pharma Private Limited, buy the company report.
Board of directors of Baxil Pharma Private Limited
Baxil Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Virendra Kumar Sharma | Additional Director | 21 Dec 2023 | 2 Years 10 Months | Current |
| Anil Singh Also directs: Bhagwant Infra Developers Private Limited, Baxil India Nidhi Limited, Concrete Technologies Private Limited and 1 more | Director | 17 Jan 2014 | 12 Years 9 Months | Current |
| Asha Singh Also directs: Bhagwant Infra Developers Private Limited, Baxil India Nidhi Limited, Concrete Technologies Private Limited and 1 more | Director | 28 Dec 2005 | 20 Years 10 Months | Current |
Peer comparison
Baxil Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Parthvimeda Gau Pharma Private Limited | ₹3.63 Cr (FY 2025) | 42698.0% | Ahmedabad, Gujarat, India | |||
| Baxil Pharma Private Limitedthis company | ₹3.62 Cr (FY 2025) | ₹3.69 Lakh | 1% | -47.0% | 17 | Delhi, India |
| Captalo Pharma Private Limited | ₹3.61 Cr (FY 2024) | 304.0% | Ahmedabad, Gujarat, India | |||
| Ceza Formulations Private Limited | ₹3.6 Cr (FY 2024) | 50.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Baxil Pharma Private Limited, buy the company report.
Auditor
Baxil Pharma Private Limited is audited by VINOD AJAY & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VINOD AJAY & ASSOCIATES | FY 2024 | 013144N |
Shareholding
The shareholding of Baxil Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Baxil Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Jul 2010 | 10237147 | Others | ₹90 Lakh | Open | |
| 11 Jul 2007 | 10061838 | Punjab National Bank | ₹2 Cr | Satisfied | |
| 11 Jul 2007 | 10061843 | Punjab National Bank | ₹2.5 Cr | Satisfied |
To see the full charge records of Baxil Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Baxil Pharma Private Limited has 23 court cases on record: 23 filed against it. 5 cases are pending and 18 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 23 | 23 | 5 |
Cases on record (5 of 23)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by M/S. Shubham Pharmachem Pvt. Ltd. | Pending |
| District court, Panchkula, Haryana | Criminal miscellaneous application | Filed against the company by M/S Medisys Biotech Pvt Ltd. | Disposed |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed against the company by M/S Medisys Biotech Pvt Ltd. | Disposed |
| District court, Haridwar, Uttarakhand | Criminal case | Filed against the company by Union of India | Pending |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed against the company by Rays Pharmachem Through Its Prop Alok Aggarwal | Pending |
To see the full case history of Baxil Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Baxil Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Baxil Pharma Private Limited has a workforce of 17 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Baxil Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AACCB8894L1Z4 | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Baxil Pharma Private Limited, buy the company report.
Recent activity
Baxil Pharma Private Limited has 5 board changes on record since 2005: 3 appointments and 2 cessations. The latest: Virendra Kumar Sharma was appointed as Additional Director on 21 Dec 2023.
2 earlier events are in the company report.
Frequently asked questions
Baxil Pharma is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 December 2005 (21+ years old) and is registered under CIN U24232DL2005PTC144166.
Baxil Pharma has 3 current directors:
- Virendra Kumar Sharma - Additional Director
- Anil Singh - Director
- Asha Singh - Director
The latest financial statements of Baxil Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Baxil Pharma is 05AACCB8894L1Z4, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Baxil Pharma is U24232DL2005PTC144166. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Baxil Pharma has 23 court cases on record: 23 filed against it. 5 are pending.
Baxil Pharma was incorporated on 28 December 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Baxil Pharma by revenue are Parthvimeda Gau Pharma Private Limited, Captalo Pharma Private Limited, Ceza Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Virendra Kumar Sharma was appointed as Additional Director on 21 Dec 2023. Swati Singh ceased to be Director on 08 Apr 2016. Anil Singh was appointed as Director on 17 Jan 2014. Baxil Pharma has 5 board changes on record in total.
Baxil Pharma can be reached through the website baxilpharma.com. Its registered office is in Delhi, India.
The registered office of Baxil Pharma is at Village Chilla Saronda Bangar In The Abadi Of Block – B New Ashok Nagar, Illaqa Shahdara, Delhi, India – 110096.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
